{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:29:39Z","timestamp":1777872579673,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,15]],"date-time":"2015-02-15T00:00:00Z","timestamp":1423958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13071-015-0695-7","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T10:47:35Z","timestamp":1424170055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia"],"prefix":"10.1186","volume":"8","author":[{"given":"Adugna","family":"Endale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berhanu","family":"Erko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fitsum","family":"Weldegebreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengistu","family":"Legesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,15]]},"reference":[{"key":"695_CR1","unstructured":"WHO. Onchocerciasis Control in the WHO African Region: Current Situation and Way Forward. Report of Regional Committee for Africa; 2007. Available: http:\/\/www.who.int\/iris\/handle\/10665\/1845. [Accessed: July 26, 2014]."},{"key":"695_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2883-2-2","volume":"2","author":"Y Dadzie","year":"2003","unstructured":"Dadzie Y, Neira M, Hopkins D. Final report of the Conference on the eradicability of Onchocerciasis. Filaria J. 2003;2:2.","journal-title":"Filaria J"},{"key":"695_CR3","first-page":"1","volume":"1","author":"M Rasheed","year":"2007","unstructured":"Rasheed M. Onchocerciasis in different regions of Ethiopia. Int J Par Dis. 2007;1:1\u201315.","journal-title":"Int J Par Dis"},{"key":"695_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1756-3305-4-205","volume":"4","author":"G Ken","year":"2011","unstructured":"Ken G, Adrian H, Mauricio S. Onchocerciasis from arrival to near elimination. Parasit Vectors. 2011;4:205\u201318.","journal-title":"Parasit Vectors"},{"key":"695_CR5","volume-title":"Prevention of blindness and visual impairment","author":"WHO","year":"2011","unstructured":"WHO. Prevention of blindness and visual impairment. Geneva: World Health Organization; 2011."},{"key":"695_CR6","first-page":"5","volume":"16","author":"WHO","year":"2010","unstructured":"WHO. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. JAF. 2010;16:5\u201323.","journal-title":"JAF"},{"key":"695_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1756-3305-5-240","volume":"5","author":"K Deribe","year":"2012","unstructured":"Deribe K, Meribo K, Gebre T, Hailu A, Ali A, Aseffa A, et al. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012;5:240.","journal-title":"Parasit Vectors"},{"key":"695_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1756-3305-7-98","volume":"7","author":"F Weldegebreal","year":"2014","unstructured":"Weldegebreal F, Medhin G, Weldegebriel Z, Legesse M. Assessment of community\u2019s knowledge, attitude and practice about onchocerciasis and community directed treatment with Ivermectin in Quara District, northwestern Ethiopia. Parasit Vectors. 2014;7:98.","journal-title":"Parasit Vectors"},{"key":"695_CR9","first-page":"1","volume":"4","author":"T Bulto","year":"1998","unstructured":"Bulto T, Workineh W, Taticheff S, Kebede A, Tilahun D. Mass treatment of Onchocerchiasis with Ivermectin at Bebeka Coffee Plantation in Ethiopia: Operational aspects for drug distribution and adverse reaction observed. Ethiop J Health Dev. 1998;4:1\u20135.","journal-title":"Ethiop J Health Dev"},{"key":"695_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1741-7015-5-9","volume":"5","author":"JC Vieira","year":"2007","unstructured":"Vieira JC, Cooper PJ, Lovato R, Mancero T, Rivera J, Proa\u00f1o R, et al. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med. 2007;5:9.","journal-title":"BMC Med"},{"key":"695_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0140-6736(93)90002-X","volume":"341","author":"A Abiose","year":"1993","unstructured":"Abiose A, Jones BR, Cousens SN, Murdoch I, Cassels-Brown A. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet. 1993;341:130\u20134.","journal-title":"Lancet"},{"key":"695_CR12","first-page":"229","volume":"75","author":"S Cousens","year":"1997","unstructured":"Cousens S, Cassels-Brown A, Murdoch I, Babalola O, Jatau D. Impact of annual dosing with ivermectin on progression of onchocercal visual field loss. Bull World Health Organ. 1997;75:229\u201336.","journal-title":"Bull World Health Organ"},{"key":"695_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1046\/j.1365-3156.1998.00339.x","volume":"3","author":"WR Brieger","year":"1998","unstructured":"Brieger WR, Awedoba AK, Eneanya CI, Hagan M, Ogbuagu KF. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Trop Med Int Health. 1998;3:951\u201361.","journal-title":"Trop Med Int Health"},{"key":"695_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1371\/journal.pmed.0030371","volume":"3","author":"M Basanez","year":"2006","unstructured":"Basanez M, Churcher T. River blindness: a success story under threat. PLoS Med. 2006;3:371.","journal-title":"PLoS Med"},{"key":"695_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.2218502","volume":"250","author":"HR Taylor","year":"1990","unstructured":"Taylor HR, Pacqu\u00e9 M, Mu\u00f1oz B, Greene BM. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science. 1990;250:116\u20138.","journal-title":"Science"},{"key":"695_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-3305-3-48","volume":"3","author":"D Yirga","year":"2010","unstructured":"Yirga D, Deribe K, Woldemichael K, Wondafrash M, Kassahun W. Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia. Parasit Vectors. 2010;3:48.","journal-title":"Parasit Vectors"},{"key":"695_CR17","series-title":"WHO Technical Report","volume-title":"Report of a WHO Expert Committee on onchocerciasis control","author":"WHO","year":"1995","unstructured":"WHO. Report of a WHO Expert Committee on onchocerciasis control, WHO Technical Report, vol. 852. Geneva: World Health Organization; 1995."},{"key":"695_CR18","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.socscimed.2007.01.018","volume":"64","author":"U Amazigo","year":"2007","unstructured":"Amazigo U, Okeibunor JC, Matovu V, Zour\u00e9 H, Bump J, Seketeli A. Performance versus predictors: evaluating sustainability in community-directed treatment projects of the African Programme for Onchocerciasis Control. Soc Sci Med. 2007;64:2070\u201382.","journal-title":"Soc Sci Med"},{"key":"695_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3156.2002.00826.x","volume":"7","author":"WR Brieger","year":"2002","unstructured":"Brieger WR, Otusanya SA, Oke GA, Oshiname FO, Adeniyi JD. Factors associated with coverage in community directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria. Trop Med Int Health. 2002;7:11\u20138.","journal-title":"Trop Med Int Health"},{"key":"695_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1179\/136485905X24201","volume":"99","author":"NB Semiyaga","year":"2005","unstructured":"Semiyaga NB, Lalobo O, Ndyomugyenyi R. Refusal to take ivermectin: the associated \u2018risk\u2019 factors in Hoima district, Uganda. Ann Trop Med Parasitol. 2005;99:165\u201372.","journal-title":"Ann Trop Med Parasitol"},{"key":"695_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4314\/eamj.v83i6.9440","volume":"83","author":"TL Lakwo","year":"2006","unstructured":"Lakwo TL, Gasarasi DB. Non-adherence to community directed treatment with ivermectin for onchocerciasis control in Rungwe district, southwest Tanzania. East Afr Med J. 2006;83:326\u201332.","journal-title":"East Afr Med J"},{"key":"695_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-3156.2005.01436.x","volume":"10","author":"F Nuwaha","year":"2005","unstructured":"Nuwaha F, Okware J, Ndyomugyenyi R. Predictors of compliance with community-directed ivermectin treatment in Uganda. Trop Med Int Health. 2005;10:659\u201367.","journal-title":"Trop Med Int Health"},{"key":"695_CR23","volume-title":"Health management information system report","author":"Gambella Regional Health Bureau (GRHB)","year":"2012","unstructured":"Gambella Regional Health Bureau (GRHB). Health management information system report. southwest Ethiopia: Gambella; 2012."},{"key":"695_CR24","first-page":"46","volume":"92","author":"BA Boatin","year":"1998","unstructured":"Boatin BA, Hougard JM, Alley ES, Akpoboua LK, Yam\u00e9ogo L. The impact of Mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol. 1998;92:46\u201360.","journal-title":"Ann Trop Med Parasitol"},{"key":"695_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1179\/000349802125000664","volume":"96","author":"UV Amazigo","year":"2002","unstructured":"Amazigo UV, Obono M, Dadzie KY, Remme J, Jiya J. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002;96:75\u201392.","journal-title":"Ann Trop Med Parasitol"},{"key":"695_CR26","first-page":"237","volume":"75","author":"WA Oyibo","year":"1998","unstructured":"Oyibo WA, Fagbenro-Beyiku AF. Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria. East Afr Med J. 1998;75:237\u201342.","journal-title":"East Afr Med J"},{"key":"695_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1756-3305-4-152","volume":"4","author":"WR Brieger","year":"2011","unstructured":"Brieger WR, Okeibunor JC, Abiose AO, Wanji S, Elhassan E, Ndyomugyenyi R, et al. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria. Parasit Vectors. 2011;4:152.","journal-title":"Parasit Vectors"},{"key":"695_CR28","first-page":"78","volume-title":"Compliance in Health Care","author":"MH Becker","year":"1979","unstructured":"Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH, Taylor DW. Patient perceptions and compliance: recent studies of the health belief model. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in Health Care, vol. 8. Baltimore: Johns Hopkins University Press; 1979. p. 78\u2013109."},{"key":"695_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1471-4922(01)02112-2","volume":"17","author":"F Richard","year":"2001","unstructured":"Richard F, Boatin B, Saurebrey M, Seketeli A. Control of onchocerciasis today: status and challenges. Trends Parasitol. 2001;17:558\u201363.","journal-title":"Trends Parasitol"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0695-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-015-0695-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0695-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0695-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:19:14Z","timestamp":1630570754000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-015-0695-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s13071-015-0695-7","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,15]]},"assertion":[{"value":"20 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}